Signal transducer and activator of transcription 5a influences mammary epithelial cell survival and tumorigenesis

Cell Growth and Differentiation

Volumn 10, Issue 10, 1999, Pages 685-694

  Humphreys, Robin C ^a   Hennighausen, Lothar ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROLACTIN; TRANSFORMING GROWTH FACTOR ALPHA;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER SURVIVAL; CARCINOGENESIS; CELL DEATH; CELL SURVIVAL; DEPHOSPHORYLATION; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GENE DELETION; HUMAN; HUMAN CELL; HUMAN TISSUE; LACTATION; MAMMARY GLAND FUNCTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; REPRODUCIBILITY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL DIVISION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; EPITHELIAL CELLS; FEMALE; MAMMARY GLANDS, ANIMAL; MICE; MILK PROTEINS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR ALPHA;

MUS MUSCULUS;

EID: 0032713453     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Vonderhaar, B. K. Prolactin: transport, function and receptors in mammary gland development and differentiation. In: M. C. Neville and C. W. Daniel (eds.), The Mammary Gland: Development, Regulation and Function, pp. 383-438. New York: Plenum Publishing, 1985.
2. Travers, M. T., Barber, M. C., Tonner, E., Quarrie, L., Wilde, C. J., and Flint, D. J. The role of prolactin and growth hormone in the regulation of casein gene expression and mammary cell survival: relationships to milk synthesis and secretion. Endocrinology, 137: 1530-1539, 1996.
3. Tonner, E., Quarrie, L., Travers, M., Barber, M., Logan, A., Wilde, C., and Flint, D. Does an IGF-binding protein (IGFBP) present in involuting rat mammary gland regulate apoptosis? Prog. Growth Factor Res., 6: 409-414, 1995.
4. Liu, X., Robinson, G. W., Wagner, K. U., Garrett, L., Wynshaw-Boris, A., and Hennighausen, L. Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev., 11: 179-186, 1997.
5. Bovolenta, C., Testolin, L., Benussi, L., Lievens, P. M., and Liboi, E. Positive selection of apoptosis-resistant cells correlates with activation of dominant-negative STAT5. J. Biol. Chem., 273: 20779-20784, 1998.
6. Zamorano, J., Wang, H. Y., Wang, R., Shi, Y., Longmore, G. D., and Keegan, A. D. Regulation of cell growth by IL-2: role of STAT5 in protection from apoptosis but not in cell cycle progression. J. Immunol., 160: 3502-3512, 1998.
7. Strange, R., Friis, R. R., Bemis, L. T., and Geske, F. J. Programmed cell death during mammary gland involution. Methods Cell Biol., 46: 355-368, 1995.
8. Marti, A., Feng, Z., Altermatt, H. J., and Jaggi, R. Milk accumulation triggers apoptosis of mammary epithelial cells. Eur. J. Cell Biol., 73: 158-165, 1997.
9. Lund, L. R., Romer, J., Thomasset, N., Solberg, H., Pyke, C., Bissell, M. J., Dano, K., and Werb, Z. Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways. Development (Camb.), 122: 181-193, 1996.
10. Hadsell, D. L., Greenberg, N. M., Fligger, J. M., Baumrucker, C. R., and Rosen, J. M. Targeted expression of des(1-3) human insulin-like growth factor I in transgenic mice influences mammary gland development and IGF-binding protein expression. Endocrinology, 137: 321-330, 1996.
11. Li, F., Strange, R., Friis, R. R., Djonov, V., Altermatt, H. J., Saurer, S., Niemann, H., and Andres, A. C. Expression of stromelysin-1 and TIMP-1 in the involuting mammary gland and in early invasive tumors of the mouse. Int. J. Cancer, 59: 560-568, 1994.
12. Li, M., Liu, X., Robinson, G., Bar-Peled, U., Wagner, K. U., Young, W. S., Hennighausen, L., and Furth, P. A. Mammary-derived signals activate programmed cell death during the first stage of mammary gland involution. Proc. Natl. Acad. Sci. USA, 94: 3425-3430, 1997.
13. Leonard, W. J., and O'Shea, J. J. Jaks and STATs: biological implications. Annu. Rev. Immunol., 16: 293-322, 1998.
14. Zhong, Z., Wen, Z., and Darnell, J. E., Jr. Stat3: a STAT family member activated by tyrosine phosptiorylation in response to epidermal growth factor and interleukin-6. Science (Washington DC), 264: 95-98, 1994.
15. Iwamoto, Y., Chin, Y. E., Peng, X., and Fu, X. Y. Identification of a membrane-associated inhibitor(s) of epidermal growth factor-induced signal transducer and activator of transcription activation. J. Biol. Chem., 273: 18198-18204, 1998.
16. Teglund, S., McKay, C., Schuetz, E., van Deursen, J. M., Stravopodis, D., Wang, D., Brown, M., Bodner, S., Grosveld, G., and Ihle, J. N. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell, 93: 841-850, 1998.
17. Darnell, J. E., Jr. STATs and gene regulation. Science (Washington DC), 277: 1630-1635, 1997.
18. Kirken, R. A., Malabarba, M. G., Xu, J., Uu, X., Farrar, W. L., Hennighausen, L., Larner, A. C., Grimley, P. M., and Rui, H. Prolactin stimulates serine/tyrosine phosphorylation and formation of heterocomplexes of multiple Stat5 isoforms in Nb2 lymphocytes. J. Biol. Chem., 272: 14098-14103, 1997.
19. Moriggl, R., Gouilleux-Gruart, V., Jahne, R., Berchtold, S., Gartmann, C., Liu, X., Hennighausen, L., Sotiropoulos, A., Groner, B., and Gouilleux, F. Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype. Mol. Cell. Biol., 16: 5691-5700, 1996.
20. Wang, D., Stravopodis, D., Teglund, S., Kitazawa, J., and Ihle, J. N. Naturally occurring dominant negative variants of Stat5. Mol. Cell. Biol., 16: 6141-6148, 1996.
21. Ruff-Jamison, S., Chen, K., and Cohen, S. Epidermal growth factor induces the tyrosine phosphorylation and nuclear translocation of Stat 5 in mouse liver. Proc. Natl. Acad. Sci. USA, 92: 4215-4218, 1995.
22. 730 of Stat5b in prolactin-sensitive cells. J. Biol. Chem., 273: 30218-30224, 1998.
23. Pircher, T. J., Petersen, H., Gustafsson, J. A., and Haldosen, L. A. Extracellular signal-regulated kinase (ERK) interacts with signal transducer and activator of transcription (STAT) 5a. Mol. Endocrinol., 13: 555-565, 1999.
24. Wartmann, M., Cella, N., Hofer, P., Groner, B., Liu, X., Hennighausen, L., and Hynes, N. E. Lactogenic hormone activation of Stat5 and transcription of the β-casein gene in mammary epithelial cells is independent of p42 ERK2 mitogen-activated protein kinase activity. J. Biol. Chem., 271: 31863-31868, 1996.
25. Dickson, R. B., and Lippman, M. E. Growth factors in breast cancer. Endocr. Rev., 16: 559-589, 1995.
26. Sandgren, E. P., Schroeder, J. A., Qui, T. H., Palmiter, R. D., Brinster, R. L., and Lee, D. C. Inhibition of mammary gland involution is associated with transforming growth factor α but not c-myc-induced tumorigenesis in transgenic mice. Cancer Res., 55: 3915-3927, 1995.
27. Schwaller, J., Frantsve, J., Aster, J., Williams, I. R., Tomasson, M. H., Ross, T. S., Peeters, P., Van Rompaey, L., Van Etten, R. A., Ilaria, R., Jr., Marynen, P., and Gilliland, D. G. Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes. EMBO J., 17: 5321-5333, 1998.
28. Wennbo, H., Gebre-Medhin, M., Gritli-Linde, A., Ohlsson, C., Isaksson, O. G., and Tornell, J. Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice. J. Clin. Investig., 100: 2744-2751, 1997.
29. Zhang, Q., Nowak, I., Vonderheid, E. C., Rook, A. H., Kadin, M. E., Nowell, P. C., Shaw, L. M., and Wasik, M. A. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. Proc. Natl. Acad. Sci. USA, 93: 9148-9153, 1996.
30. Hayakawa, F., Towatari, M., Iida, H., Wakao, H., Kiyoi, H., Naoe, T., and Saito, H. Differential constitutive activation between STAT-related proteins and MAP kinase in primary acute myelogenous leukaemia. Br. J. Haematol., 101: 521-528, 1998.
31. Yu, C. L., Jove, R., and Burakoff, S. J. Constitutive activation of the Janus kinase-STAT pathway in T lymphoma overexpressing the Lck protein tyrosine kinase. J. Immunol., 159: 5206-5210, 1997.
32. Migone, T. S., Lin, J. X., Cereseto, A., Mulloy, J. C., O'Shea, J. J., Franchini, G., and Leonard, W. J. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-1. Science (Washington DC), 269: 79-81, 1995.
33. Danial, N. N., Pernis, A., and Rothman, P. B. Jak-STAT signaling induced by the v-ab1 oncogene. Science (Washington DC), 269: 1875-1877, 1995.
34. Meydan, N., Grunberger, T., Dadi, H., Shahar, M., Arpaia, E., Lapidot, Z., Leeder, J. S., Freedman, M., Cohen, A., Gazit, A., Levitzki, A., and Roifman, C. M. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature (Lond.), 379: 645-648, 1996.
35. Quarrie, L. H., Addey, C. V., and Wilde, C. J. Apoptosis in lactating and involuting mouse mammary tissue demonstrated by nick-end DNA labelling. Cell Tissue Res., 281: 413-419, 1995.
36. Wagner, K. U., Young, W. S., III, Liu, X., Ginns, E. I., Li, M., Furth, P. A., and Hennighausen, L. Oxytocin and milk removal are required for postpartum mammary gland development. Genes Funct., 1: 233-244, 1997.
37. Tzeng, Y. J., Zimmermann, C., Guhl, E., Berg, B., Avantaggiati, M. L., and Graessmann, A. SV40 T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors. Oncogene, 16: 2103-2114, 1998.
38. Li, B., Murphy, K. L., Laucirica, R., Kittrell, F., Medina, D., and Rosen, J. M. A transgenic mouse model for mammary carcinogenesis. Oncogene, 16: 997-1007, 1998.
39. Jhappan, C., Geiser, A. G., Kordon, E. C., Bagheri, D., Hennighausen, L., Roberts, A. B., Smith, G. H., and Merlino, G. Targeting expression of a transforming growth factor β1 transgene to the pregnant mammary gland inhibits alveolar development and lactation. EMBO J., 12: 1835-1845, 1993.
40. Jager, R., Herzer, U., Schenkel, J., and Weiher, H. Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice. Oncogene, 15: 1787-1795, 1997.
41. Pittius, C. W., Sankaran, L., Topper, Y. J., and Hennighausen, L. Comparison of the regulation of the whey acidic protein gene with that of a hybrid gene containing the whey acidic protein gene promoter in transgenic mice. Mol. Endocrinol., 2: 1027-1032, 1988.
42. Liu, X., Robinson, G. W., and Hennighausen, L. Activation of Stat5a and Stat5b by tyrosine phosphorylation is tightly linked to mammary gland differentiation. Mol. Endocrinol., 10: 1496-1506, 1996.
43. Bauer, J. H., Liu, K. D., You, Y., Lai, S. Y., and Goldsmith, M. A. Heteromerization of the γc chain with the interleukin-9 receptor a subunit leads to STAT activation and prevention of apoptosis. J. Biol. Chem., 273: 9255-9260, 1998.
44. Leff, M. A., Buckley, D. J., Krumenacker, J. S., Reed, J. C., Miyashita, T., and Buckley, A. R. Rapid modulation of the apoptosis regulatory genes bcl-2 and bax by prolactin in rat Nb2 lymphoma cells. Endocrinology, 137: 5456-5462, 1996.
45. Evan, G. I., Brown, L., Whyte, M., and Harrington, E. Apoptosis and the cell cycle. Curr. Opin. Cell Biol., 7: 825-834, 1995.
46. Sartor, C. I., Dziubinski, M. L., Yu, C. L., Jove, R., and Ethier, S. P. Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells. Cancer Res., 57: 978-987, 1997.
47. David, M., Wong, L., Flavell, R., Thompson, S. A., Wells, A., Lamer, A. C., and Johnson, G. R. STAT activation by epidermal growth factor (EGF) and amphiregulin. Requirement for the EGF receptor kinase but not for tyrosine phosphorylation sites or JAK1. J. Biol. Chem., 271: 9185-9188, 1996.
48. Leaman, D. W., Pisharody, S., Flickinger, T. W., Commane, M. A., Schlessinger, J., Kerr, I. M., Levy, D. E., and Stark, G. R. Roles of JAKs in activation of STATs and stimulation of c-fos gene expression by epidermal growth factor. Mol. Cell. Biol., 16: 369-375, 1996.
49. Kirken, R. A., Malabarba, M. G., Xu, J., DaSilva, L., Erwin, R. A., Liu, X., Hennighausen, L., Rui, H., and Farrar, W. L. Two discrete regions of interleukin-2 (IL2) receptor β independently mediate IL2 activation of a PD98059/rapamycin/wortmannin-insensitive Stat5a/b serine kinase. J. Biol. Chem., 272: 15459-15465, 1997.
50. Shual, K., Ziemiecki, A., Wilks, A. F., Harpur, A. G., Sadowski, H. B., Gilman, M. Z., and Darnell, J. E. Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins. Nature (Lond.), 366: 580-583, 1993.
51. Petersen, H., and Haldosen, L. A. EGF modulates expression of STAT5 in mammary epithelial cells. Exp. Cell Res., 243: 347-358, 1998.
52. Kohlhuber, F., Rogers, N. C., Watling, D., Feng, J., Guschin, D., Briscoe, J., Witthuhn, B. A., Kotenko, S. V., Pestka, S., Stark, G. R., Ihle, J. N., and Kerr, I. M. A JAK1/JAK2 chimera can sustain α and γ interferon responses. Mol. Cell. Biol., 17: 695-706, 1997.
53. Kotenko, S. V., Izotova, L. S., Pollack, B. P., Muthukumaran, G., Paukku, K., Silvennoinen, O., Ihle, J. N., and Pestka, S. Other kinases can substitute for Jak2 in signal transaction by interferon-γ. J. Biol. Chem., 271: 17174-17182, 1996.
54. Lupu, R., Cardillo, M., Cho, C., Harris, L., Hijazi, M., Perez, C., Rosenberg, K., Yang, D., and Tang, C. The significance of heregulin in breast cancer tumor progression and drug resistance. Breast Cancer Res. Treat., 38: 57-66, 1996.
55. Sebastian, J., Richards, R. G., Walker, M. P., Wiesen, J. F., Werb, Z., Derynck, R., Hom, Y. K., Cunha, G. R., and DiAugustine, R. P. Activation and function of the epidermal growth factor receptor and erbB-2 during mammary gland morphogenesis. Cell Growth Differ., 9; 777-785, 1998.
56. Wiesen, J. F., Young, P., Werb, Z., and Cunha, G. R. Signaling through the stromal epidermal growth factor receptor is necessary for mammary ductal development. Development (Camb.), 126: 335-344, 1998.
57. Muller, W. J., Arteaga, C. L., Muthuswamy, S. K., Siegel, P. M., Webster, M. A., Cardiff, R. D., Meise, K. S., Li, F., Halter, S. A., and Coffey, R. J. Synergistic interaction of the Neu proto-oncogene product and transforming growth factor α in the mammary epithelium of transgenic mice. Mol. Cell. Biol., 16: 5726-5736, 1996.
58. Kenney, N. J., Smith, G. H., Maroulakou, I. G., Green, J. H., Muller, W. J., Callahan, R., Salomon, D. S., and Dickson, R. B. Detection of amphiregulin and Cripto-1 in mammary tumors from transgenic mice. Mol. Carcinog., 15: 44-56, 1996.
59. Huang, S., Trujillo, J. M., and Chakrabarty, S. Proliferation of human colon cancer cells: role of epidermal growth factor and transforming growth factor α. Int. J. Cancer, 52: 978-986, 1992.
60. Liu, X., Gallego, M. I., Smith, G. H., Robinson, G. W., and Hennighausen, L. Functional release of Stat5a-null mammary tissue through the activation of compensating signals including Stat5b. Cell Growth Differ., 9: 795-803, 1998.
61. Danial, N. N., Losman, J. A., Lu, T., Yip, N., Krishnan, K., Krolewski, J., Goff, S. P., Wang, J. Y., and Rothman, P. B. Direct interaction of Jak1 and v-Ab1 is required for v-Ab1-induced activation of STATs and proliferation. Mol. Cell. Biol., 18: 6795-6804, 1998.
62. Frank, D. A., and Varticovski, L. BCR/ab1 leads to the constitutive activation of Stat proteins and shares an epitope with tyrosine phosphorylated Stats. Leukemia (Baltimore), 10: 1724-1730, 1996.
63. Liu, X., Robinson, G. W., Gouilleux, F., Groner, B., and Hennighausen, L. Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue. Proc. Natl. Acad. Sci. USA, 92: 8831-8835, 1995.
64. Humphreys, R. C., Krajewska, M., Krnacik, S., Jaeger, R., Weiher, H., Krajewski, S., Reed, J. C., and Rosen, J. M. Apoptosis in the terminal endbud of the murine mammary gland: a mechanism of ductal morphogenesis. Development (Camb.), 122: 4013-4022, 1996.